AVM Two Platforms

Control of Stem Cell Biodistribution

Control of Stem Cell Biodistribution

A patent-protected novel high-dose formulation, our AugmenStem™ blocks the body’s rapid high-affinity reservoirs for stem cells.

Learn more
Fully Human Biologics Manufacturing Cell Line

Fully Human Biologics Manufacturing Cell Line

The active agent of a vaccine may be intact but inactivated or attenuated (with reduced infectivity) forms of the causative pathogens.

Learn more

What Sets Us Apart

Our innovation are driven by our values of profound respect for human life from its beginning until its natural conclusion. AVM Biotechnology certifies that its therapeutic products and technologies are engineered such that no human or human being is physically exploited or intentionally harmed.


AVM Drugs in High Unmet Disease Areas

  • Heart and Vascular Disease
  • Bone/Cartilage/Tendon Sports Medicine
  • CNS & Neuromuscular Disorders
  • Autoimmune Inflammatory
  • Heart Attack, Heart Failure, Cardiomyopathy, Stroke, CLI, PAD
  • RA, Osteoarthritis, Fracture, Tendon/Cartilage Repair, Joint Replacement, Navicular Syndrome, CKD, Atopy
  • Spinal Cord Injury, MS/MD/ALS, Cerebral Palsy, Parkinson’s, Alzheimer’s
  • Diabetes, Lupus, Kidney Disease, COPD, Colitis, Liver/Skin Diseases
  • Sensory Organ Diseases, Trauma and Injuries, Specialty and Cosmetic Procedures, Veterinary Medicine
  • AMD, Rentinitis, Corneal Repair, Stargardt Disease, Hearing Loss
  • Burns, Traumatic Brain Injury, Fractures, Wounds/Ulcers
  • Dental, Periodontal, Hair Growth, Wrinkles, Anti-Aging, Breast Augmentation
  • Cancer
  • CAR-T Immunotherapy, Stem Cell Mobilization, HSCT & BMT, GvHD, Infections, GC Lymphomas
  • Homeland Security & Military
  • Acute Radiation Syndrome
  • Better Biologics
  • Fully Human Cell Lines for General Biologic Production, e.g., “Human CHO” Cell Line
  • Boutique Biologics
  • Patient-specific Biologics for Personalized Medicine,e.g., Hemophilia